Oaktree Specialty Lending Corp (OCSL)
As-reported financials and SEC filings for Oaktree Specialty Lending Corp. The latest annual period is FY2025. The latest reported quarter is Q3 FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.
About Oaktree Specialty Lending Corp
Oaktree Specialty Lending Corp is a specialty finance company that provides customized credit solutions to middle-market companies with limited access to public or syndicated capital markets. It offers various financing options including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity, and equity co-investments. The company primarily serves companies with enterprise values between $100 million and $750 million and manages a portfolio focused on debt investments in resilient businesses.
Snapshot
Fundamentals are from SEC filings for FY2025, the latest annual period (ended September 30, 2025). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.
What changed at Oaktree Specialty Lending
- Net income fell 41.4% to $34M in FY2025.
Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.
Peer comparison
Where Oaktree Specialty Lending’s fundamentals sit among the 51 business development companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).
Oaktree Specialty Lending’s P/E of 27.2 ranks in the 89th percentile of the 38 peers with a meaningful P/E.
1 reported insider purchase (code P) totaling $21,581 in the last 90 days. For context, about 14% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →
Percentiles describe where a figure sits among business development company peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.
Institutional ownership
Held by 3 quant / multi-strat books among the superinvestors we track; no conviction manager currently reports a position.
| Investor | As of | Position value | Shares | Change |
|---|---|---|---|---|
| Two Sigma Investmentsquant | Q2 2026 | $4.1M | 340.3K | Reduced |
| Citadel Advisorsquant | Q2 2026 | $1.9M | 155.9K | Reduced |
| AQR Capital Managementquant | Q2 2026 | $1.0M | 87.4K | Added |
No longer held by: D. E. Shaw (as of Q2 2026), Millennium Management (as of Q2 2026)
From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.
Recent insider activity
Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.
| Trade date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
2026-08-12 filed 2026-08-13 | Panossian ArmenSee Remarks | Buy | 1.7K | $12.69 | $22K |
Reported non-derivative purchases and sales (codes P/S) — which may be open-market or private; excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.
Short interest
Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 2026-08-14 | 3.0M | -5.6% | 4.43 |
| 2026-07-31 | 3.2M | -12.7% | 7.05 |
| 2026-07-15 | 3.7M | +1.4% | 8.69 |
Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.
Income statement (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $33.9M | $57.9M | $117.3M | $29.2M | $237.3M |
| Diluted EPS | $0.39 | $0.72 | $1.63 | $0.48 | $4.39 |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.
Balance sheet (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Cash and equivalents | $79.6M | $64.0M | $136.4M | $23.5M | $29.3M |
| Current assets | — | — | — | — | — |
| Total assets | $3.00B | $3.20B | $3.22B | $2.65B | — |
| Current liabilities | — | — | — | — | — |
| Long-term debt | $1.49B | $1.64B | $1.60B | $1.30B | — |
| Total liabilities | $1.54B | $1.71B | $1.70B | $1.40B | — |
| Total equity | $1.47B | $1.49B | $1.52B | $1.25B | $1.31B |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.
Cash flow (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Operating cash flow | $228.4M | $19.1M | $228.8M | $22.4M | $-230.5M |
| Capital expenditure | — | — | — | — | — |
| Free cash flow | — | — | — | — | — |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.
Quarterly trend (as reported)
| Quarter | Revenue | Revenue YoY | Net income | Diluted EPS |
|---|---|---|---|---|
| Q3 FY2026 | — | — | $30.9M | $0.35 |
| Q2 FY2026 | — | — | $-18.9M | $-0.21 |
| Q1 FY2026 | — | — | $5.6M | $0.06 |
| Q4 FY2025 | — | — | $24.6M | $0.28 |
| Q3 FY2025 | — | — | $38.4M | $0.44 |
| Q2 FY2025 | — | — | $-36.2M | $-0.42 |
| Q1 FY2025 | — | — | $7.2M | $0.09 |
| Q4 FY2024 | — | — | $36.9M | $0.45 |
Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.
Company facts
Selected SEC filings
Largest Financials peers
Monitor OCSL
Get an alert when Oaktree Specialty Lending files something material, see which superinvestors own it, and ask its filings a question with cited answers.
Monitor OCSL freeIncludes one free filing-grounded research answer. Or check your whole portfolio, no account needed.
Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.